Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parametersVictoria Sánchez, Mar Masiá, Catalina Robledano, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 10, 2016
Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infectionHéctor Meijide, Álvaro Mena, Iria Rodríguez-Osorio, et al.
Frontiers in Immunology|June 15, 2026
IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppressionAlexandre Pérez-González, Jacobo Alonso-Domínguez, Inés Martínez-Barros, et al.
AIDS (London, England)|April 26, 2017
Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfectedHéctor Meijide, Sonia Pértega, Iria Rodríguez-Osorio, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 6, 2013
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapyPablo Barreiro, Pablo Labarga, José V Fernández-Montero, et al.
Expert Opinion on Pharmacotherapy|April 30, 2013
Hepatitis C therapy with HCV NS5B polymerase inhibitorsVincent Soriano, Eugenia Vispo, Carmen de Mendoza, et al.
AIDS (London, England)|February 20, 2010
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patientsPablo Labarga, Jose Medrano, Eduardo Seclen, et al.
AIDS Research and Human Retroviruses|July 29, 2003
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donorCarlos Toro, Berta Rodés, Félix Colino, et al.
Antiviral Therapy|May 11, 2011
Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patientsAna Treviño, Carmen de Mendoza, Patricia Parra, et al.
Antiviral Therapy|February 2, 2012
Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in SpainEva Poveda, Eugenia Vispo, Pablo Barreiro, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parametersVictoria Sánchez, Mar Masiá, Catalina Robledano, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 10, 2016
Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infectionHéctor Meijide, Álvaro Mena, Iria Rodríguez-Osorio, et al.
Frontiers in Immunology|June 15, 2026
IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppressionAlexandre Pérez-González, Jacobo Alonso-Domínguez, Inés Martínez-Barros, et al.
AIDS (London, England)|April 26, 2017
Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfectedHéctor Meijide, Sonia Pértega, Iria Rodríguez-Osorio, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 6, 2013
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapyPablo Barreiro, Pablo Labarga, José V Fernández-Montero, et al.
Expert Opinion on Pharmacotherapy|April 30, 2013
Hepatitis C therapy with HCV NS5B polymerase inhibitorsVincent Soriano, Eugenia Vispo, Carmen de Mendoza, et al.
AIDS (London, England)|February 20, 2010
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patientsPablo Labarga, Jose Medrano, Eduardo Seclen, et al.
AIDS Research and Human Retroviruses|July 29, 2003
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donorCarlos Toro, Berta Rodés, Félix Colino, et al.
Antiviral Therapy|May 11, 2011
Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patientsAna Treviño, Carmen de Mendoza, Patricia Parra, et al.
Antiviral Therapy|February 2, 2012
Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in SpainEva Poveda, Eugenia Vispo, Pablo Barreiro, et al.
Pageof 15